MedTrace Logo

Echocardiographic Manifestation in Patient With COVID-19 （EARLY-MYO COVID-19）

NCT04352842 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2020-05-19

No results posted yet for this study

Summary

The cardiovascular effects of coronavirus disease 2019 (COVID-19) are not yet fully known. We conducted a prospective and dynamic echocardiographic study to investigate the cardiac structural and functional changes in COVID-19 patients in intensive care unit (ICU).

Conditions

  • Covid19
  • Echocardiography

Interventions

OTHER

Echocardiography

An expert with 17-year professional experience performed all the echocardiography examinations using a GE LOGIQTM e portable color ultrasound diagnostic machine (GE Healthcare, WI, USA) that was specially used in the contaminated area. Two-dimensional and Doppler echocardiographic measurements were conducted following the recommendations of the American Society of Echocardiography

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Jun Pu, M.D · Renji Hospital, School of Medicine, Shanghai Jiaotong University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-21
Primary Completion
2020-04-08
Completion
2020-04-08

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04352842 on ClinicalTrials.gov